1011 — China NT Pharma Co Cashflow Statement
0.000.00%
- HK$569.40m
- HK$925.55m
- CNY24.16m
Annual cashflow statement for China NT Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -149 | -54.3 | -33.4 | -53.5 | -26.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 64.7 | 82.7 | -2.7 | 40.6 | 13.9 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -93 | -13.2 | 80.7 | 3.15 | 6.33 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -135 | 36.2 | 50.5 | -9.07 | -5.39 |
| Capital Expenditures | -0.646 | -4.49 | -10.7 | -0.178 | -0.159 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 258 | 9.02 | -11.4 | -0.011 | 0.007 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 258 | 4.53 | -22.1 | -0.189 | -0.152 |
| Financing Cash Flow Items | -43.3 | -19.7 | -19.2 | -9.98 | -19.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -125 | -46.7 | -29 | 12.7 | 4.87 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.61 | -2.45 | -0.396 | 8.1 | -2.4 |